companies innovating in obesity treatment glp-1 drugs 2025 to reshape pharma landscape 2025’s Breakthrough GLP-1 Obesity Treatments:

Allulose is a monosaccharide (single-unit sugar) that occurs naturally in small amounts in wheat, figs, and raisins

This may be due to altered -cell function in diabetic patients, which impairs the efficacy of GLP-1(936)

Reversely, down-regulation of miR-758 intensified GLP-1's activity and demonstrated substantial promotion benefits, whereas overexpression of miR-758 abolished the GLP-1-mediated ABCA1 expression

Participants received either 4 mg mazdutide, 6 mg mazdutide, or placebo once weekly for 48 weeks

It is significantly boosting the risk of diabetes development

In those with obesity, retatrutide 12 mg reduced UACR by 31.5% and increased eGFR by 8.5 mL/min/1.73 m